CAS No. 910249-50-2

6-Quinolinecarbonitrile,7-chloro-1,2-dihydro-4-hydroxy-3-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxo-

Catalog No.: 2165498
Name: 6-Quinolinecarbonitrile,7-chloro-1,2-dihydro-4-hydroxy-3-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxo-
CAS: 910249-50-2
Formula: C20H13ClN4O2

Filed under: Carbonitrile

Inquire about this product → | Safety data

About 6-Quinolinecarbonitrile,7-chloro-1,2-dihydro-4-hydroxy-3-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxo-

6-Quinolinecarbonitrile,7-chloro-1,2-dihydro-4-hydroxy-3-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxo- is a chemical compound registered under CAS number 910249-50-2, with the molecular formula C20H13ClN4O2 and a molecular weight of about 376.8 g/mol. ChemToTech supplies 6-Quinolinecarbonitrile,7-chloro-1,2-dihydro-4-hydroxy-3-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]-2-oxo- for laboratory research and bulk production; product code 2165498. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 910249-50-2
Molecular Formula: C20H13ClN4O2
Molecular Weight: 376.8 g/mol

Related Keywords

pyrazol

quinolinecarbonitrile

Quinoline

1H-1,5-Benzodiazepine, 7-chloro-2,3-dihydro-2,2,4-trimethyl-

1H-1-Benzazepine-4-carboxamide,7-[4-(2-butoxyethoxy)phenyl]-N-[3-chloro-4-[[(4-propyl-4H-1,2,4-triazol-3-yl)methyl]thio]phenyl]-2,3-dihydro-1-(2-methylpropyl)-

1,5-Naphthalenedisulfonic acid, 2-hydroxy-

1H-1,5-Benzodiazepin-6-ol, 2,4-dimethyl-, compd. with2,4,6-trinitrophenol (1:1)

4-Morpholinecarboxylic acid,5-[(1S,2S)-2-(acetylamino)-3-[3-fluoro-5-[(3-methyl-2-butenyl)oxy]phenyl]-1-hydroxypropyl]-2-(2,2-dimethylpropoxy)-3-methyl-, 1,1-dimethylethylester, (2R,3S,5R)-

1,5-Naphthalenedisulfonic acid,3-[[2-(acetylamino)-4-[[7-(acetylamino)-1-hydroxy-3-sulfo-2-naphthalenyl]azo]-5-methoxyphenyl]azo]-, trisodium salt

102969-85-7

1H-1-Benzazepine-4-carboxylic acid, 1-acetyl-5-(1-piperidinyl)-, methylester

1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 7-bromo-1-methyl-

4-Morpholinecarboxylic acid,5-[(1S,2S)-2-[bis(phenylmethyl)amino]-3-(3,5-difluorophenyl)-1-(phenylmethoxy)propyl]-2-hydroxy-, 1,1-dimethylethyl ester, (2R,5R)-

4-Morpholinecarboxylic acid,5-[(1S,2S)-2-[bis(phenylmethyl)amino]-3-(3,5-difluorophenyl)-1-(phenylmethoxy)propyl]-2-[3-fluoro-2-(fluoromethyl)-2-methylpropoxy]-,1,1-dimethylethyl ester, (2R,5R)-

1H-1-Benzazepine-4-carboxylic acid, 7-bromo-2,3-dihydro-1-methyl-,methyl ester

Ethanimidic acid, N-[[4-(dipropylamino)-3,5-dinitrophenyl]sulfonyl]-,butyl ester

38452-51-6

1H-1-Benzazepine-4-carboxamide,7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-1-propyl-N-[4-[(2-pyridinylthio)methyl]phenyl]-

1H-1,4-Diazepine,hexahydro-1-[(4E)-5-(3,4,5-trimethoxyphenyl)-4-pentenyl]-

4-Morpholinecarboxylic acid,5-[(1S,2S)-2-(acetylamino)-3-(3-fluoro-5-propoxyphenyl)-1-hydroxypropyl]-2-(cyclopropylmethoxy)-, 1,1-dimethylethyl ester, (2R,5R)-

1H-1,5-Benzodiazepine, 7-methoxy-2,4-dimethyl-, compd. with2,4,6-trinitrophenol (1:1)

1,5-Naphthalenedisulfonic acid,2-[[6-[[4-chloro-6-[[4-[[2-nitro-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]-, sodium salt

1H-1,5-Benzodiazepine-2,4(3H,5H)-dione, 1-phenyl-

22316-50-3

1H-1,5-Benzodiazepine-2,4(3H,5H)-dione,1-(2-hydroxyethyl)-5-(2-pyridinyl)-7-(trifluoromethyl)-

1H-1-Benzazepine-4-carboxamide,N-(4-bromophenyl)-2,3,4,5-tetrahydro-1-methyl-2,5-dioxo-

1H-1,5-Benzodiazepine,2,3-dihydro-2-(4-methoxyphenyl)-4-[2-(4-methoxyphenyl)ethenyl]-, (E)-

Ethanimidic acid, N-[2,5-dimethyl-4-[3-(trifluoromethyl)phenoxy]phenyl]-,methyl ester

1,5-Naphthalenedisulfonic acid,3-[[6-[[4-chloro-6-[[3-[[2-[methyl(2-sulfoethyl)amino]ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulfo-2-naphthalenyl]azo]-,tetrasodium salt

1,5-Methano-1H-3-benzazepine-7-carbonitrile, 2,3,4,5-tetrahydro-

328055-95-4

1H-1,4-Diazepine,hexahydro-1,4-bis[[(4S)-4-(1-methylethenyl)-1-cyclohexen-1-yl]methyl]-

1H-1-Benzazepine-4-carboxamide,7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-1-propyl-N-[4-[(R)-[(4-propyl-4H-1,2,4-triazol-3-yl)methyl]sulfinyl]phenyl]-

1H-1-Benzazepine-1-carboxylic acid,7-ethyl-2,3,4,5-tetrahydro-5-hydroxy-8-(trifluoromethyl)-,1,1-dimethylethyl ester, (5R)-

1H-1,5-Benzodiazepine-2,4(3H,5H)-dione,7-chloro-1-(2-ethoxyethyl)-5-phenyl-

1,5-Methano-1H-3-benzazepine, 7-chloro-2,3,4,5-tetrahydro-

1,5-Dioxaspiro[5.5]undecane-2,4-dione, 3-[(phenylamino)methylene]-

75307-52-7

4-Morpholinecarboxylic acid,5-[(1S,2S)-2-(acetylamino)-3-(3-bromo-5-fluorophenyl)-1-hydroxypropyl]-2-(2,2-dimethylpropoxy)-3-methyl-, 1,1-dimethylethyl ester,(2R,3S,5R)-

3-Oxazolidinecarboxylic acid,4-[(1R,2S)-2-[bis(phenylmethyl)amino]-3-(3,5-difluorophenyl)-1-(phenylmethoxy)propyl]-2,2-dimethyl-, 1,1-dimethylethyl ester, (4R)-

1,5-Methano-2,4-benzodioxepin,1,5,5a,6,7,9a-hexahydro-3-(4-nitrophenyl)-8-pentyl-

1H-1-Benzazepine-4-carboxamide,7-[4-(2-butoxyethoxy)phenyl]-2,3-dihydro-N-[4-[[[4-(2-methylpropyl)-4H-1,2,4-triazol-3-yl]methyl]thio]phenyl]-1-propyl-

1H-1,5-Benzodiazepine-2,4(3H,5H)-dione,3-azido-1,5-bis(2,2-dimethylpropyl)-

1H-1-Benzazepine-4-carboxamide,7-[4-(2-butoxyethoxy)phenyl]-N-[3-chloro-4-[hydroxy(1-oxido-2-pyridinyl)methyl]phenyl]-2,3-dihydro-1-(2-methylpropyl)-